Creating Waves of Awareness
Menactra vaccine is a safe and effective vaccine against meningococcal disease.1-4 Although rare, meningococcal disease is a serious bacterial illness that includes meningitis (the inflammation of the protective layer surrounding the brain and spinal cord) and septicemia (blood poisoning).2,3,5,6 Between 1000 and 2600 cases of meningococcal disease occur in the United States annually.2 Every year, the disease quickly ends the lives of children and can leave its survivors permanently disabled.1,3,8,9 Fortunately, you’re not powerless. Menactra vaccine can help. Menactra vaccine helps protect children
Indication Menactra vaccine is given to persons 2 through 55 years of age for active immunization against invasive meningococcal disease caused by N meningitidis serogroups A, C, Y, and W-135. Menactra vaccine will not stimulate protection against infection caused by N meningitidis other than serogroups A, C, Y, and W-135.
Side effects to Menactra vaccine include injection site pain, redness, and swelling; headache or fatigue. Other side effects may occur. Vaccination should be avoided by persons with known hypersensitivity (severe allergic reaction) to any ingredient of the vaccine, including latex (which is used in the vial stopper), or by any persons previously diagnosed with Guillain-Barré syndrome. There is a potential for an increased chance of getting Guillain-Barré syndrome following vaccination. Vaccination with Menactra vaccine may not protect all individuals.